Literature DB >> 9394290

What studies of fusion peptides tell us about viral envelope glycoprotein-mediated membrane fusion (review).

S R Durell1, I Martin, J M Ruysschaert, Y Shai, R Blumenthal.   

Abstract

This review describes the numerous and innovative methods used to study the structure and function of viral fusion peptides. The systems studied include both intact fusion proteins and synthetic peptides interacting with model membranes. The strategies and methods include dissecting the fusion process into intermediate stages, comparing the effects of sequence mutations, electrophysiological patch clamp methods, hydrophobic photolabelling, video microscopy of the redistribution of both aqueous and lipophilic fluorescent probes between cells, standard optical spectroscopy of peptides in solution (circular dichroism and fluorescence) and attenuated total reflection-Fourier transform infrared spectroscopy of peptides bound to planar bilayers. Although the goal of a detailed picture of the fusion pore has not been achieved for any of the intermediate stages, important properties useful for constraining the development of models are emerging. For example, the presence of alpha-helical structure in at least part of the fusion peptide is strongly correlated with activity; whereas, beta-structure tends to be less prevalent, associated with non-native experimental conditions, and more related to vesicle aggregation than fusion. The specific angle of insertion of the peptides into the membrane plane is also found to be an important characteristic for the fusion process. A shallow penetration, extending only to the central aliphatic core region, is likely responsible for the destabilization of the lipids required for coalescence of the apposing membranes and fusion. The functional role of the fusion peptides (which tend to be either nonpolar or aliphatic) is then to bind to and dehydrate the outer bilayers at a localized site; and thus reduce the energy barrier for the formation of highly curved, lipidic 'stalk' intermediates. In addition, the importance of the formation of specific, 'higher-order' fusion peptide complexes has also been shown. Recent crystallographic structures of core domains of two more fusion proteins (in addition to influenza haemagglutinin) has greatly facilitated the development of prototypic models of the fusion site. This latter effort will undoubtedly benefit from the insights and constraints gained from the studies of fusion peptides.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9394290     DOI: 10.3109/09687689709048170

Source DB:  PubMed          Journal:  Mol Membr Biol        ISSN: 0968-7688            Impact factor:   2.857


  78 in total

1.  Implicit solvent model studies of the interactions of the influenza hemagglutinin fusion peptide with lipid bilayers.

Authors:  D Bechor; N Ben-Tal
Journal:  Biophys J       Date:  2001-02       Impact factor: 4.033

2.  Mutational evidence for an internal fusion peptide in flavivirus envelope protein E.

Authors:  S L Allison; J Schalich; K Stiasny; C W Mandl; F X Heinz
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

3.  A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype.

Authors:  H Qiao; R T Armstrong; G B Melikyan; F S Cohen; J M White
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

4.  Ultrastructural characterization of peptide-induced membrane fusion and peptide self-assembly in the lipid bilayer.

Authors:  A S Ulrich; W Tichelaar; G Förster; O Zschörnig; S Weinkauf; H W Meyer
Journal:  Biophys J       Date:  1999-08       Impact factor: 4.033

5.  Minimal aggregate size and minimal fusion unit for the first fusion pore of influenza hemagglutinin-mediated membrane fusion.

Authors:  J Bentz
Journal:  Biophys J       Date:  2000-01       Impact factor: 4.033

6.  The fusion domain of HIV gp41 interacts specifically with heparan sulfate on the T-lymphocyte cell surface.

Authors:  J Cladera; I Martin; P O'Shea
Journal:  EMBO J       Date:  2001-01-15       Impact factor: 11.598

7.  Conformational intermediates and fusion activity of influenza virus hemagglutinin.

Authors:  T Korte; K Ludwig; F P Booy; R Blumenthal; A Herrmann
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

8.  A host-guest system to study structure-function relationships of membrane fusion peptides.

Authors:  X Han; L K Tamm
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

9.  Stochastic simulation of hemagglutinin-mediated fusion pore formation.

Authors:  S Schreiber; K Ludwig; A Herrmann; H G Holzhütter
Journal:  Biophys J       Date:  2001-09       Impact factor: 4.033

10.  Amino acid sequence requirements of the transmembrane and cytoplasmic domains of influenza virus hemagglutinin for viable membrane fusion.

Authors:  G B Melikyan; S Lin; M G Roth; F S Cohen
Journal:  Mol Biol Cell       Date:  1999-06       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.